PPT-Introduction to Hazardous Drugs in An Occupational Setting

DATE PLACE Disclaimer This presentation contains information on the general principles for safe handling of hazardous drugs This presentation cannot account for individual variation among facilities and cannot be considered inclusive of all proper methods of occupational safety It is the responsibility of the facility management and staff to determine the best course of occupational safety for operations The American Cancer Society and its partners assume no responsibility for any injury or damage to persons or property arising out of or related to any use of these materials or for any errors or omissions Last updated February 2020. Cytotoxic. and Hazardous Drugs. Drug Distribution and Control: Preparation and Handling–Technical Assistance Bulletins. Slides rearranged and prepared by : . GROUP . B . LIM KOK HAN . MD HASHIMIE BADDRUDIN BIN MAT HASSAN. Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 1. Module 1 Training Overview. Hazardous drug categories. Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 2. Before Beginning Module 2. Please review . Module 1. Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 1. Module 1 Training Overview. Hazardous drug categories. Consultation Education and Training Division. Michigan Occupational Safety and Health Administration . www.michigan.gov/miosha. 517-284-7720. Module 2. Before Beginning Module 2. Please review . Module 1. Are You Prepared?. Alexandra . Sible. , . PharmD. NMPhA. Mid-Winter Meeting. January 28, 2018. Objectives. Upon completion of this activity, participants will be able to…. 1. Describe the background and purpose of USP General Chapters 797 and 800 and explain key differences between the two chapters. . Patricia C. Kienle, RPh, MPA, FASHP. Disclosure. Patricia Kienle is a member of the USP Compounding Expert Committee but this talk is not affiliated with nor endorsed by USP. Objectives - Pharmacists. USP General Chapter <800>. Shawn Becker, MS, BSN. Senior Director Healthcare Quality and Safety. US Pharmacopeia . Questions. True or False: USP is a government agency.. True or False: USP is a nonprofit organization.. Pharmacy . Technician Education. ASHP Section Advisory Group on Advancing Pharmacy Practice with Technicians 2018-2019. Table of Contents . Didactic overview of types of hazardous drugs (HD) and their risks. Drugs. CWT Clinical/Nursing Education . 2. Overview. Handling Hazardous Drugs in Healthcare Settings . United States Pharmacopeia, Chapter <800> . is a federally mandated regulation that broadens the definition of hazardous drugs and outlines safe practices for employees handling hazardous drugs.. EH&S Safety | 02/2018 Page 1 of 1 3 Chemotherap y and Other Hazardous Drugs Safe Use Guidelines I. Introduction II. Laboratory Planning and Preparation for Use III. Engineering Controls IV. Perso Clinical Manager, Doylestown Hospital. Pharmacist Consultant, Medisca Network. Hazardous Drugs: Risks and Regulations. Conflict Disclosure. Dr. Roussel has no conflicts of interest and has not received compensation for this program. ,. European Biosafety Network,. 5 December 2019. About the EBN. Established in 2009 by the founding partners, the Spanish General Council of Nursing and the British public services union UNISON.. The Network is an inclusive organisation made up of national and European professional institutions, representative associations, unions and other interested parties committed to biological and occupational safety in healthcare throughout the European Union.. Hazardous Drug Rules . & Updates for Pharmacy Buyers. Katrina . Kagler. Harper, . PharmD. , MBA, . BCPS. Learning objectives. Explain the risk of hazardous drug exposure for healthcare workers. Summarize updates to .